Cellectis (CLLS) EPS (Basic) (2015 - 2026)
Cellectis (CLLS) recorded quarterly EPS (Basic) of -$0.0 in Q1 2026, up 66.53% quarter-over-quarter from -$0.0 in Q4 2025, and up 51.44% on a YoY basis from -$0.0 in Q1 2025.
Cellectis (CLLS) EPS (Basic) (2015 - 2026) Analysis & Trends
Cellectis' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 51.44% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$56514.3 (down 117976958.72% YoY), while the FY2025 annual figure was -$0.67, down 63.41% from the prior year.
- EPS (Basic) was -$0.0 for Q1 2026 at Cellectis, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.06 in Q4 2024 to a low of -$56514.3 in Q2 2025.
- Historically, EPS (Basic) has averaged -$4319.5 across 5 years, with a median of -$0.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 114.95% in 2024, then slumped 1318815661.21% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.59 in 2022, then retreated by 15.83% to -$0.68 in 2023, then surged by 108.7% to $0.06 in 2024, then slumped by 107.54% to -$0.0 in 2025, then surged by 66.53% to -$0.0 in 2026.
- The last three EPS (Basic) figures came in at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and $0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -56,514.29 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.06 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.68 |
| Sep 30, 2023 | -0.31 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.59 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -16,916.07 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.55 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | -0.01 |